文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

高迁移率族蛋白B1在内毒素诱导脓毒症大鼠肠黏膜屏障损伤中的作用

[Role of high mobility group box 1 in intestinal mucosal barrier injury in rat with sepsis induced by endotoxin].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2020-01-01
一句话结论内毒素诱导的脓毒症大鼠中HMGB1表达上调并激活NF-κB介导肠黏膜屏障损伤,HMGB1抑制剂EP可减轻该损伤。

该研究用腹腔注射内毒素脂多糖复制脓毒症大鼠模型,设磷酸缓冲液对照组,并观察HMGB1抑制剂EP溶液(40 mg/kg)的干预效果。建模72小时后检测血浆D-乳酸和二胺氧化酶反映黏膜屏障通透性,并行小肠组织病理、超微结构及Occludin、HMGB1、NF-κB p65的mRNA和蛋白表达检测。结果示LPS组肠黏膜结构损伤、通透性升高,HMGB1及NF-κB p65表达上调、Occludin表达下调;EP干预组Chiu评分、D-乳酸、二胺氧化酶均低于LPS组,Occludin表达高于LPS组,HMGB1和NF-κB p65表达低于LPS组。作者认为机制可能是HMGB1上调促进NF-κB活化介导炎症级联反应而损伤肠黏膜。

要点

  • 脓毒症大鼠肠黏膜屏障受损:LPS组血浆D-乳酸5.30±0.16 mmol/L、二胺氧化酶30.47±1.11 U/L,均高于PBS对照组。
  • HMGB1抑制剂EP溶液40 mg/kg腹腔注射后,Chiu评分1.60±0.48 vs LPS组3.40±0.48,D-乳酸3.30±0.22 vs 5.30±0.16 mmol/L,二胺氧化酶23.66±0.97 vs 30.47±1.11 U/L,均P<0.05。
  • EP干预组Occludin mRNA 0.82±0.05 vs LPS组0.37±0.08,Occludin蛋白1.04±0.09 vs 0.75±0.11,均P<0.05。
  • EP干预组HMGB1 mRNA 1.63±0.10 vs LPS组3.57±0.10,NF-κB p65 mRNA 1.47±0.09 vs 2.62±0.13,蛋白表达亦均低于LPS组(均P<0.05)。
  • 作者认为脓毒症肠黏膜损伤机制可能是HMGB1表达上调促进下游NF-κB活化,介导炎症级联反应。

适用人群与场景

  • 腹腔注射内毒素脂多糖复制的脓毒症大鼠模型;设磷酸缓冲液对照组。

处置流程与药物剂量

  • HMGB1抑制剂EP溶液按40 mg/kg腹腔注射干预脓毒症大鼠,建模72小时后取材检测。

研究设计与关键结果

  • 动物实验:大鼠腹腔注射LPS复制脓毒症模型,设PBS对照组,观察HMGB1抑制剂EP溶液(40 mg/kg)干预效果;建模72小时后取腹主动脉血检测。
  • LPS组小肠组织病理及超微结构示肠黏膜明显肿胀、部分腺体不完整、中性粒细胞浸润增多、微绒毛细胞缺失、排列紊乱、紧密连接数量显著减少,均较PBS对照组明显。
  • LPS组反映黏膜屏障通透性的D-乳酸和二胺氧化酶水平、HMGB1及下游NF-κB p65的mRNA和蛋白表达均显著高于PBS对照组,小肠Occludin mRNA和蛋白表达显著低于PBS对照组。
  • EP干预组小肠组织Chiu评分和血浆D-乳酸、二胺氧化酶水平显著低于LPS组:Chiu评分1.60±0.48 vs 3.40±0.48,D-乳酸3.30±0.22 vs 5.30±0.16 mmol/L,二胺氧化酶23.66±0.97 vs 30.47±1.11 U/L,均P<0.05。
  • EP干预组Occludin mRNA和蛋白表达显著高于LPS组:mRNA(2-ΔΔCt)0.82±0.05 vs 0.37±0.08,蛋白(Occludin/β-actin)1.04±0.09 vs 0.75±0.11,均P<0.05。
  • EP干预组HMGB1和NF-κB p65的mRNA及蛋白表达显著低于LPS组:HMGB1 mRNA(2-ΔΔCt)1.63±0.10 vs 3.57±0.10,HMGB1蛋白(HMGB1/β-actin)1.40±0.07 vs 1.87±0.07;NF-κB p65 mRNA(2-ΔΔCt)1.47±0.09 vs 2.62±0.13,NF-κB p65蛋白(NF-κB p65/β-actin)1.24±0.14 vs 1.60±0.13,均P<0.05。

证据类型、等级与局限

  • 证据类型:动物实验(大鼠脓毒症模型)。
  • 局限:原文未报告局限性

对床旁实践的改变

  • 该动物实验提示HMGB1抑制剂EP可减轻内毒素诱导脓毒症大鼠的肠黏膜屏障损伤,作者认为机制可能为HMGB1上调促进NF-κB活化介导炎症级联反应;原文未据此给出临床推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the role and mechanism of the high mobility group box 1 (HMGB1) in intestinal mucosal barrier injury in rat with sepsis induced by endotoxin lipopolysaccharide (LPS).

METHODS: The rats were given intraperitoneal injection of LPS to reproduce a model of sepsis. The effect of HMGB1 inhibitor EP solution (40 mg/kg) on sepsis was observed, and phosphate buffer (PBS) control group was set up. Seventy-two hours after modeling, abdominal aortic blood was obtained, and enzyme-linked immunosorbent assay (ELISA) was used to measure the plasma levels of D-lactic acid and diamine oxidase (DAO) of mucosal barrier permeability. The pathological changes of the intestinal mucosal were observed with light microscope and the Chiu score was recorded. The intestinal mucosal ultrastructural changes were observed with electron microscopy. Real-time quantitative reverse transcription-polymerase chain reaction (RT-qPCR) and Western Blot were used to measure the mRNA and protein expressions of Occludin, inflammatory factor HMGB1 and its downstream signal molecule nuclear transcription factor-κB p65 (NF-κB p65) in the rat small intestine.

RESULTS: The results of histopathology and ultrastructure of the small intestine showed that in the LPS group, the intestinal mucosa tissue swelled obviously, part of the glands were incomplete, the infiltration of neutrophils increased, themicrovillus cells were absent, arranged indisorder, and the number of tight connections significantly reduced compared with the PBS control group. The levels of D-lactic acid and DAO indicating mucosal barrier permeability, the levels of inflammatory factor HMGB1 and its downstream signaling molecule NF-κB p65 mRNA and protein expressions in the LPS group were significantly higher than those in the PBS control group, and the mRNA and protein expression of Occludin in the small intestine was significantly lower than that in the PBS control group, suggesting that the intestinal mucosal barrier function in septic rats was damaged, permeability increased, and the structure was damaged. After the administration of the HMGB1 inhibitor EP, the intestinal mucosal barrier damage was significantly improved. The performance was as follows: the Chiu score of the small intestine tissue and the plasma D-lactic acid and DAO levels in the EP intervene group were significantly lower than those in the LPS group [Chiu score: 1.60±0.48 vs. 3.40±0.48, D-lactic acid (mmol/L): 3.30±0.22 vs. 5.30±0.16, DAO (U/L): 23.66±0.97 vs. 30.47±1.11, all P < 0.05]. Occludin mRNA and protein expression levels were significantly higher than those in the LPS group [Occludin mRNA (2-ΔΔCt): 0.82±0.05 vs. 0.37±0.08, Occludin protein (Occludin/β-actin): 1.04±0.09 vs. 0.75±0.11, both P < 0.05], while the mRNA and protein expression levels of HMGB1 and NF-κB p65 were significantly lower than those in the LPS group [HMGB1 mRNA (2-ΔΔCt): 1.63±0.10 vs. 3.57±0.10, HMGB1 protein (HMGB1/β-actin): 1.40±0.07 vs. 1.87±0.07; NF-κB p65 mRNA (2-ΔΔCt): 1.47±0.09 vs. 2.62±0.13, NF-ΚB p65 protein (NF-κB p65/β-actin): 1.24±0.14 vs. 1.60±0.13, all P < 0.05].

CONCLUSIONS: Intestinal mucosal barrier function of septic rats was damaged, permeability increased, and structure was damaged. The mechanism may be that the expression of inflammatory factor HMGB1 was up-regulated and promoted the activation of its downstream signaling molecule NF-κB, thereby mediated the inflammatory cascade reaction and caused damage to the intestinal mucosa.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Chen S, Xiu G, Zhou J, et al. [Role of high mobility group box 1 in intestinal mucosal barrier injury in rat with sepsis induced by endotoxin]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020. PMID: 32788013. doi:10.3760/cma.j.cn121430-20200109-00126

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。